Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27964972 | 0.77 | SMN1; SMN2 (0.40) | SMN1; SMN2CA1CA2CA14CA12 | |
| SCHEMBL5528316 | 0.72 | CYP4F2 (0.38) | SMN1; SMN2CA1CA2L3MBTL1KMT2A | |
| Dalapon SCHEMBL30302614 | 0.71 | SMN1; SMN2 (0.36) | SMN1; SMN2CA1CA2CA14CA12 | |
| SCHEMBL453120 | 0.69 | SMN1; SMN2 (0.50) | SMN1; SMN2CA1CA2CA14CA12 | |
| SCHEMBL1332029 | 0.69 | — | — | |
| SCHEMBL270012 | 0.69 | — | — | |
| SCHEMBL2864267 | 0.69 | SMN1; SMN2 (0.48) | SMN1; SMN2CA1CA2CA14CA12 | |
| SCHEMBL80876 | 0.68 | HSP90AA1 (0.44) | SMN1; SMN2CA1CA2CA14CA12 | |
| SCHEMBL37355 | 0.67 | — | — | |
| SCHEMBL15902979 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4307033-A | Preparation of 3,3-dimethyl-cyclopropane-1,1,2-tricarboxylic acid derivatives and intermediates therefor | BAYER AKTIENGESELLSCHAFT (DE) | 1981-12-22 | — | — | US | disclosed |